Navigation Links
Gastrografin®

ProductsGastrografin®
Company Bracco Diagnostics, Inc.
Item Gastrografin®
Features 
Description Gastromiro® is a formulation of iopamidol in orange-flavoured aqueous solution for gastroenterography by oral administration or, where necessary, by enema.Its non-ionic nature permits a considerable improvement in the radiological exploration of the gastrointestinal tract compared to traditional contrast media. Thanks to its low osmolality, Gastromiro does not absorb water in the intestinal lumen, and is not diluted; this results in good contrast in both proximal and distal loops.
Info Bracco Diagnostics, Inc.
Customer Service: (800) 631-5245
Web site: http://www.bracco.com/usa/en-US/

Related medicine products :

1. Optimark®
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Mini-type 1/1 (mm), opening width 4.0 mm and length 8.2 mm.
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Temporary mini-type 1/1 (mm), opening width 5.0 mm and length 6 mm.
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Fenestrated large type 1/1 (mm), opening width 8.0 mm and length 7.5 mm.
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Fenestrated large type 1/1 (mm), opening width 8.0 mm and length 10 mm.
Medicine Products:
(Date:7/9/2008)...tes In-Store and Online Marketing to Create Unique...TTSBURGH and NEW YORK, July 9 /PRNewswire-FirstCal...largest global specialty retailer of,nutritional p...ource of,health information, today announced a mul... awareness and understanding of the importance of ...
(Date:7/9/2008)...y 9 /PRNewswire-FirstCall/ -- Nyer Medical Group,...DCO South Medical Supplies,Inc., ("ADCO South") i...,announced that its pharmacy division, D.A.W. Inc....ior Living, Inc. to be the preferred pharmacy,prov...cilities in,Massachusetts. The award was made at t...
(Date:7/9/2008)...RNewswire-FirstCall/ - MDS Inc. (TSX: MDS; NYSE:,M...o the global life,sciences markets, today announce...ed (AECL) with notice of arbitration proceedings. ...fill its contractual obligations,under its 2006 in...f not,granted, seeking significant monetary damage...
(Date:7/9/2008)... Radiotherapy Clinics of Georgia (RCOG) has beg...ing campaign. RCOG is renowned for their ProstRcis...st documented prostate cancer cure rates in the wo...B) July 9, 2008 -- Radiotherapy Clinics of Georgia...r click campaign that incorporates geo targeting f...
Breaking Medicine News(10 mins):Health News:GNC and WebMD Announce Agreement To Provide Consumers with Health and Nutritional Information While Promoting the Benefits of a Healthy Lifestyle 2Health News:GNC and WebMD Announce Agreement To Provide Consumers with Health and Nutritional Information While Promoting the Benefits of a Healthy Lifestyle 3Health News:Nyer Medical Group, Inc. Announces Sale of Company's Florida Medical-Surgical Division; Pharmacy Division Awarded Two-Year Preferred Supplier Contract 2Health News:Nyer Medical Group, Inc. Announces Sale of Company's Florida Medical-Surgical Division; Pharmacy Division Awarded Two-Year Preferred Supplier Contract 3Health News:MDS Commences Arbitration against AECL over Cancelled MAPLE Project and Files $1.6 Billion Court Claim against AECL and the Government of Canada 2Health News:MDS Commences Arbitration against AECL over Cancelled MAPLE Project and Files $1.6 Billion Court Claim against AECL and the Government of Canada 3Health News:Localized Online Marketing Campaign Serves to Raise Awareness of Prostate Cancer Treatment 2Health News:Localized Online Marketing Campaign Serves to Raise Awareness of Prostate Cancer Treatment 3
...th Ministers of Southern States will be held here ...ing chikungunya,Karnataka Health Minister R Ashok ...of submitting a memorandum to the Centre seeking f...f medicines, he told reporters here. The Karnataka...
...igures of pregnancy-related deaths and to reduce m...s decided to conduct a detailed audit to find out/...ortality ratio (MMR) in Rajasthan is 677. MMR is t...rths and is a measure of the death of risk once a ...
... the rescued five-year-old boy Prince, who was tra...eclared that the child was safe and did not// suff...ed boy was being brought to state capital Chandiga...e super-specialty Post-Graduate Institute of Medic...
...n anti-smoking lessons in the classroom to keep sc...rding to a recent review of studies.// There is li...e effective in the long term in preventing kids fr...homas, lead reviewer and a professor in the family...
Other Medicine News:Health News:Rajasthan to Conduct Audit to Find Out the Cause of Maternal Mortality 2Health News:Students Light Up Despite School Anti-Smoking Programs 2Health News:Students Light Up Despite School Anti-Smoking Programs 3
(Date:7/7/2008)...e/ -- OrbusNeich today announced that data,present...nese Society of,Interventional Cardiology demonstr...ter outcomes when compared to drug-eluting stents....,s principal,investigator and a professor with the...rdiology, Department of Clinical Medicine and Card...
(Date:7/7/2008)...fruit is Top Performer in the Body, SEATTLE, July...l when,it comes to their antioxidant powers in the...bility compared to other antioxidant-rich fruits a... in the Journal of the,American College of Nutriti...cals called flavonoids that,may have the power to ...
(Date:7/3/2008)...swire-FirstCall/ -- Medivation, Inc.,(Nasdaq: MDV...ence at 5:00,p.m. EDT on Monday, July 7, to discus...nd, placebo-controlled Phase 2 clinical trial of,d...ce/Webcast Details, To participate in the live ca... telephone, please dial 877-419-6590 from the U.S....
(Date:7/3/2008)...BRIDGE Massachusetts, July 3,/PRNewswire-FirstCall...logy company, Jerini AG for an equity purchase pr... (HAE) product, FIRAZYR(R), to its Human Genetic ...global sales expected to be around $350-400 milli...e environment, - Expected to be accretive for Non...
Breaking Medicine Technology:Data Presented at Annual Meeting of Japanese Society of Interventional Cardiology Demonstrate OrbusNeich's Genous(TM) Bio-engineered R Stent(TM) Has Better Outcomes When Compared to Drug-Eluting Stents 2Data Presented at Annual Meeting of Japanese Society of Interventional Cardiology Demonstrate OrbusNeich's Genous(TM) Bio-engineered R Stent(TM) Has Better Outcomes When Compared to Drug-Eluting Stents 3Kiwifruit: Antioxidant Power in Quantity and Quality 2Medivation to Host Conference Call at 5 p.m. EDT Monday to Discuss Top-Line Phase 2 Study Results in Huntington's Disease 2Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent 2Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent 3Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent 4Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent 5Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent 6Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent 7Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent 8Complementary Excerpt Available from Best Practices 3A Resources Structure and Processes to Optimize Pharmaceutical Sales Communications 17241 1Complementary Excerpt Available from Best Practices 3A Resources Structure and Processes to Optimize Pharmaceutical Sales Communications 17241 2Gene Therapy in Rats Reduces Cocaine Use 17237 1Gene Therapy in Rats Reduces Cocaine Use 17237 2Dealing Cervical Cancer a Knockout Blow 17234 1Dealing Cervical Cancer a Knockout Blow 17234 2Dealing Cervical Cancer a Knockout Blow 17234 3Best Practice Database 3A Valuable Strategies for Pharmaceutical Product Launches 17230 1Best Practice Database 3A Valuable Strategies for Pharmaceutical Product Launches 17230 2
...HICAGO, June 21, 2007 /PRNewswire-FirstCall/ -- Ad...ced positive results from,Trial CL-06, the first o...assess the safety and effectiveness of cethromycin... of community,acquired pneumonia (CAP). In the stu...imary endpoint of per protocol clinical,cure rate ...
...ummary: Pharmexa-Epimmune, the U.S.-based subsidia...s influenza vaccine,program today at the Influenza...Influenza VI," held in Toronto, Ontario, Canada. T...o induce,cell-mediated immune responses can protec...uenza virus challenge. , HORSOLM, Denmark, June 21...
Other Medicine Technology:Cethromycin Achieves Primary Endpoint in Pivotal Phase 3 Pneumonia,Clinical Trial 2Cethromycin Achieves Primary Endpoint in Pivotal Phase 3 Pneumonia,Clinical Trial 3Cethromycin Achieves Primary Endpoint in Pivotal Phase 3 Pneumonia,Clinical Trial 4Cethromycin Achieves Primary Endpoint in Pivotal Phase 3 Pneumonia,Clinical Trial 5Pharmexa A/S (DK) - Pharmexa presents data from influenza program 2